Home › Funds › ORBIMED ADVISORS LLC › LLY

ORBIMED ADVISORS LLC position in LLY

ELI LILLY CO · Health Care

ORBIMED ADVISORS LLC reported holding 257,900 shares of LLY (ELI LILLY CO) in its Q2 2026 13F filing — a position valued at US$309.3M, representing 6.22% of its reported portfolio and ranking #3 among its reported holdings. ORBIMED ADVISORS LLC has disclosed LLY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)257.90K sh
Reported value held$309.33M
Portfolio Weight6.22%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's LLY position evolved

ORBIMED ADVISORS LLC first disclosed a stake in LLY in Q3 2023 at 186,000 shares (US$99.9M). The position peaked in Q4 2025 at 301,200 shares, worth US$323.7M. Across 12 filings, ORBIMED ADVISORS LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 257,900 shares valued at US$309.3M — an increase of 21,100 shares quarter over quarter.. Notable position changes include a 96% increase in Q4 2023 (shares rose 34% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 186.00K $99.91M New
Q4 2023 365.40K $213.00M Add
Q1 2024 360.80K $280.69M Reduce
Q2 2024 337.60K $305.66M Reduce
Q3 2024 337.60K $299.09M Hold
Q4 2024 337.60K $260.63M Hold
Q1 2025 337.60K $278.83M Hold
Q2 2025 337.60K $263.17M Hold
Q3 2025 301.20K $229.82M Reduce
Q4 2025 301.20K $323.69M Hold
Q1 2026 236.80K $217.80M Reduce
Q2 2026 257.90K $309.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (ELI LILLY CO) is a Health Care company. 38 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held LLY?

ORBIMED ADVISORS LLC has disclosed LLY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ORBIMED ADVISORS LLC's current position in LLY?

As of Q2 2026, ORBIMED ADVISORS LLC holds 257.90K shares of LLY (ELI LILLY CO), valued at $309.33M, representing 6.22% of its reported portfolio and ranking #3.

Has ORBIMED ADVISORS LLC been buying or selling LLY?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in LLY. The position peaked in Q4 2025 at 301.20K shares.

Which other funds hold LLY?

Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, BlackRock Inc, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.